Strategy for the Management of Macular Edema in Retinal Vein Occlusion: The European VitreoRetinal Society Macular Edema Study

Table 2

Baseline demographic patient data for BRVO.

	Number of cases	Mean pretreatment Va LogMAR (Snellen)	Standard deviation	Mean number of treatments
Anti-VEGF alone	140	0.72 (0.2)	0.42	3.83
PPV with ILM peeling alone	48	0.87 (0.13)	0.42	1.00
Dexamethasone implant alone	17	0.59 (0.25)	0.27	1.49
Triamcinolone alone	13	0.76 (0.18)	0.38	1.00

BRVO: branch retinal vein occlusion.
VEGF: vascular endothelial growth factor.
PPV: pars plana vitrectomy.
ILM: internal limiting membrane.